First patient enrolled in a Phase III study with QUTENZA® in post-surgical neuropathic pain
/PRNewswire/ -- Grünenthal announced today that its U.S. subsidiary, Averitas Pharma Inc., enrolled the first patient in the randomised, double-blind trial...
Source: prnewswire.com